{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:25:38Z","timestamp":1791419138241,"version":"4.3.3"},"reference-count":64,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1659,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1111\/j.1365-2516.2010.02449.x","type":"journal-article","created":{"date-parts":[[2011,2,22]],"date-time":"2011-02-22T06:18:17Z","timestamp":1298355497000},"page":"383-392","source":"Crossref","is-referenced-by-count":47,"title":["Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations"],"prefix":"10.1111","volume":"17","author":[{"given":"C.","family":"HERMANS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"DE MOERLOOSE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"FISCHER","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"HOLSTEIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"KLAMROTH","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"LAMBERT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"LAVIGNE-LISSALDE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"PEREZ","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"RICHARDS","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"DOLAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"ON BEHALF OF THE EUROPEAN HAEMOPHILIA THERAPY STANDARDISATION BOARD","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","volume":"6","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"issue":"Suppl. 4","key":"10.1111\/j.1365-2516.2010.02449.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2008.01732.x","article-title":"Physiopathology of haemophilic arthropathy","volume":"14","author":"Lafeber","year":"2008","journal-title":"Haemophilia"},{"issue":"Suppl. 6","key":"10.1111\/j.1365-2516.2010.02449.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2516.2008.01882.x","article-title":"Haemophilic arthropathy: the importance of the earliest haemarthroses and consequences for treatment","volume":"14","author":"Roosendaal","year":"2008","journal-title":"Haemophilia"},{"issue":"2 Suppl. 1","key":"10.1111\/j.1365-2516.2010.02449.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1053\/j.seminhematol.2008.03.017","article-title":"Blood-induced joint disease: the confluence of dysregulated oncogenes, inflammatory signals, and angiogenic cues","volume":"45","author":"Valentino","year":"2008","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/art.22304","article-title":"Exposure of human cartilage tissue to low concentrations of blood for a short period of time leads to prolonged cartilage damage: an in vitro study","volume":"56","author":"Jansen","year":"2007","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1136\/ard.2007.081182","article-title":"Degenerated and healthy cartilage are equally vulnerable to blood-induced damage","volume":"67","author":"Jansen","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1002\/art.20284","article-title":"Initiation of degenerative joint damage by experimental bleeding combined with loading of the joint: a possible mechanism of hemophilic arthropathy","volume":"50","author":"Hooiveld","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00003086-199710000-00004","article-title":"Conservative treatment of hemarthrosis for prevention of hemophilic synovitis","volume":"343","author":"Ribbans","year":"1997","journal-title":"Clin Orthop Relat Res"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2516.2006.01296.x","article-title":"Current European practice in immune tolerance induction therapy in patients with haemophilia and inhibitors","volume":"12","author":"Astermark","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","article-title":"Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy","volume":"348","author":"Palareti","year":"1996","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1002\/1529-0131(199804)41:4<736::AID-ART23>3.0.CO;2-P","article-title":"A prospective study of the safety of joint and soft tissue aspirations and injections in patients taking warfarin sodium","volume":"41","author":"Thumboo","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2004.05110.x","article-title":"Dose and response in haemophilia - optimization of factor replacement therapy","volume":"127","author":"Srivastava","year":"2004","journal-title":"Br J Haematol"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/bmj.2.5544.79","article-title":"Antihaemophilic globulin: preparation by an improved cryoprecipitation method and clinical use","volume":"2","author":"Brown","year":"1967","journal-title":"Br Med J"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1542\/peds.43.1.26","article-title":"Administration of single doses of AHF (factor VIII) concentrates in the treatment of hemophilic hemarthroses","volume":"43","author":"Honig","year":"1969","journal-title":"Pediatrics"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0022-3476(74)80405-1","article-title":"Early treatment of hemophilic hemarthroses with minimal dose of new factor 8 concentrate","volume":"85","author":"Britton","year":"1974","journal-title":"J Pediatr"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB16|cit16","first-page":"223","article-title":"Current concepts in the management of hemophilia","volume":"12","author":"Abildgaard","year":"1975","journal-title":"Semin Hematol"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V50.1.181.181","article-title":"Early treatment of bleeding episodes with 10\u2003U\/kg of factor VIII","volume":"50","author":"Ashenhurst","year":"1977","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJM197708182970724","article-title":"Lower doses of factor VIII for hemophilia","volume":"297","author":"Penner","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1056\/NEJM197712012972218","article-title":"Doses of factor VIII for hemophilic bleeding","volume":"297","author":"Weiss","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1182\/blood.V51.4.763.763","article-title":"Early treatment of hemophilia with minimal doses of factor VIII or factor IX","volume":"51","author":"Ripa","year":"1978","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-0038-1666930","article-title":"Dose requirement for replacement therapy in hemophilia A","volume":"42","author":"Allain","year":"1979","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(79)91328-X","article-title":"Minimum effective dose of intermediate factor-VIII concentrate in haemophiliacs on home therapy","volume":"1","author":"Stirling","year":"1979","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(80)90659-5","article-title":"Double-blind controlled trial of three dosage regimens in treatment of haemarthroses in haemophilia A","volume":"1","author":"Aronstam","year":"1980","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0022-3476(81)80844-X","article-title":"The identification of high-risk elbow hemorrhages in adolescents with severe hemophilia A","volume":"98","author":"Aronstam","year":"1981","journal-title":"J Pediatr"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/bmj.284.6318.790","article-title":"Low doses of factor VIII for selected ankle bleeds in severe haemophilia A","volume":"284","author":"Aronstam","year":"1982","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB26|cit26","first-page":"2428","article-title":"A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group","volume":"83","author":"Bray","year":"1994","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1055\/s-0037-1613925","article-title":"Sucrose formulated recombinant human antihemophilic factor VIII is safe and efficacious for treatment of hemophilia A in home therapy - International Kogenate-FS Study Group","volume":"83","author":"Abshire","year":"2000","journal-title":"Thromb Haemost"},{"issue":"2 Suppl. 4","key":"10.1111\/j.1365-2516.2010.02449.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0037-1963(01)90108-8","article-title":"Clinical evaluation of B-domain deleted recombinant factor VIII in previously treated patients","volume":"38","author":"Courter","year":"2001","journal-title":"Semin Hematol"},{"issue":"Suppl. 2","key":"10.1111\/j.1365-2516.2010.02449.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1351-8216.2001.00131.x","article-title":"European data of a clinical trial with a sucrose formulated recombinant factor VIII in previously treated haemophilia A patients","volume":"8","author":"Rothschild","year":"2002","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB30|cit30","volume-title":"Guidelines for the Management of Haemophilia","author":"World Federation of Haemophilia","year":"2009"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB31|cit31","volume-title":"National Guidelines - Management of Haemophilia","author":"Medical Advisory Committee of Haemophilia Foundation of New Zealand","year":"2009"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1046\/j.1365-2516.1998.4404213.x","article-title":"Treatment protocol of haemophilia and other congenital bleeding disorders in Italy. Italian Association of Hemophilia Centers (AICE)","volume":"4","author":"Gringeri","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2516.2000.00361.x","article-title":"Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy","volume":"6","author":"Santagostino","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB34|cit34","volume-title":"Le traitement de l\u2019h\u00e9mophilie","author":"GREHCO (Groupe de Recherche et d\u2019Etudes de l\u2019H\u00e9mophilie du Centre et de l\u2019Ouest)","year":"2002"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB35|cit35","first-page":"170","volume-title":"Querschnitts-Leitlinien (BAK) zur Therapie mit blutkomponenten und Plasmaderivaten","author":"Bundes\u00e4rztekammer (German Medical Association)","year":"2009"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-2516.1998.4404214.x","article-title":"Guidelines on treatment of haemophilia in Sweden","volume":"4","author":"Berntorp","year":"1998","journal-title":"Haemophilia"},{"issue":"2 Pt 2","key":"10.1111\/j.1365-2516.2010.02449.x-BIB37|cit37","first-page":"126","article-title":"Guideline for the treatment of haemophilia in South Africa","volume":"98","author":"Mahlangu","year":"2008","journal-title":"S Afr Med J"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2516.2010.02449.x-BIB38|cit38","first-page":"84","article-title":"Protocols for the treatment of haemophilia and von Willebrand disease","volume":"6","author":"Kasper","year":"2000","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1046\/j.1365-2516.1998.440474.x","article-title":"Management of haemophilia in the developing world","volume":"4","author":"Srivastava","year":"1998","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1365-2516.2003.00723.x","article-title":"Analgesic use and pain coping among patients with haemophilia","volume":"9","author":"Elander","year":"2003","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-2516.2008.01653.x","article-title":"Paracetamol\/acetaminophen usage in haemophilia: more caution needed?","volume":"14","author":"van Veen","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1365-2516.2006.01311.x","article-title":"Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia","volume":"12","author":"Rattray","year":"2006","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1182\/blood-2004-09-3501","article-title":"Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy","volume":"107","author":"Tsoukas","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2516.2005.01087.x","article-title":"Rofecoxib as adjunctive therapy for haemophilic arthropathy","volume":"11","author":"Rattray","year":"2005","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/01.hco.0000245740.85829.4f","article-title":"Cyclooxygenase-2 inhibitors and cardiovascular risk","volume":"21","author":"Solomon","year":"2006","journal-title":"Curr Opin Cardiol"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/ajh.2830270107","article-title":"Intraarticular methylprednisolone therapy in hemophilic arthropathy","volume":"27","author":"Shupak","year":"1988","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJM197005212822123","article-title":"Management of hemarthrosis","volume":"282","author":"Kisker","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJM197003192821201","article-title":"Double-blind studies on the use of steroids in the treatment of acute hemarthrosis in patients with hemophilia","volume":"282","author":"Kisker","year":"1970","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/ptj\/44.3.169","article-title":"Hyaluronidase by iontophoresis in the treatment of edema","volume":"44","author":"Magistro","year":"1964","journal-title":"Phys Ther"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB50|cit50","first-page":"99","article-title":"[Cutaneous iontophoresis of hyaluronidase in the treatment of hemorrhages in hemophilic patients]","volume":"14","author":"Gandini","year":"1977","journal-title":"Electrodiagn Ther"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/ptj\/75.6.554","article-title":"Iontophoresis: applications in transdermal medication delivery","volume":"75","author":"Costello","year":"1995","journal-title":"Phys Ther"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB52|cit52","first-page":"1","article-title":"Articular bleeding (hemarthrosis) in haemophilia - an orthopedist\u2019s point of view","volume":"23","author":"Rodriguez-Merchan","year":"2008","journal-title":"The Treatment of Haemophilia (World Federation of Haemophilia Monograph)"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB53|cit53","first-page":"522","article-title":"Post-traumatic hemarthrosis of the knee and arthroscopy. Review of 161 cases","volume":"127","author":"Cazenave","year":"1990","journal-title":"J Chir (Paris)"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/145749690209100410","article-title":"Acute traumatic hemarthrosis of the knee. Is routine arthroscopic examination necessary? A study of 320 consecutive patients","volume":"91","author":"Sarimo","year":"2002","journal-title":"Scand J Surg"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB55|cit55","first-page":"1319","article-title":"Aspiration treatment of acute haemarthroses","volume":"23","author":"Kerr","year":"1965","journal-title":"Bibl Haematol"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1136\/ard.31.5.423-a","article-title":"Controlled trial of joint aspiration in acute haemophilic haemarthrosis","volume":"31","author":"Ingram","year":"1972","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB57|cit57","first-page":"285","article-title":"Arthrocentesis of the knee in acute hemophilic arthropathy","volume":"122","author":"Banta","year":"1975","journal-title":"West J Med"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2516.2008.01854.x","article-title":"Acute haemarthrosis of the hip joint: rapid convalescence following ultrasound-guided needle aspiration","volume":"15","author":"Robertson","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB59|cit59","first-page":"394","article-title":"The haemophiliac joint and its treatment by physical methods","volume":"50","author":"Gregg","year":"1964","journal-title":"Physiotherapy"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1365-2516.2008.01701.x","article-title":"Domiciliary application of CryoCuff in severe haemophilia: qualitative questionnaire and clinical audit","volume":"14","author":"d\u2019Young","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1302\/0301-620X.69B1.3546324","article-title":"Diagnostic ultrasound in haemophilia","volume":"69","author":"Wilson","year":"1987","journal-title":"J Bone Joint Surg Br"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1182\/blood-2004-06-2063","article-title":"Successful treatment of severe bleeding in hemophilic target joints by selective angiographic embolization","volume":"105","author":"Mauser-Bunschoten","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2516.2008.01842.x","article-title":"Successful angiographic embolization of recurrent elbow and knee joint bleeds in seven patients with severe haemophilia","volume":"15","author":"Klamroth","year":"2009","journal-title":"Haemophilia"},{"key":"10.1111\/j.1365-2516.2010.02449.x-BIB64|cit64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2516.2007.01638.x","article-title":"Value added: increasing the power to assess treatment outcome in joint haemorrhages","volume":"14","author":"Donfield","year":"2008","journal-title":"Haemophilia"}],"container-title":["Haemophilia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2516.2010.02449.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2516.2010.02449.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T06:14:29Z","timestamp":1685945669000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2516.2010.02449.x"}},"subtitle":["ACUTE HAEMARTHROSIS IN HAEMOPHILIA: LITERATURE REVIEW AND SURVEY"],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":64,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,5]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2516.2010.02449.x","relation":{},"ISSN":["1351-8216"],"issn-type":[{"value":"1351-8216","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,15]]}}}